Not logged in β-Catenin interacts with canonical RBPs including MSI2 to associate with a Wnt signalling mRNA network in myeloid leukaemia cells Wagstaff, M.; Sevim, O.; Goff, A.; Raynor, M.; Park, H.; Mancini, E. J.; Nguyen, D. T. T.; Chevassut, T.; Blair, A.; Castellano, L.; Newbury, S.; Towler, B.; Morgan, R. G. Share Save
Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia Kamizela, Aleksandra E.; Leongamornlert, Daniel; Williams, Nicholas; Wang, Xin; Nyamondo, Kudzai; Dawson, Kevin; Chapman, Michael Spencer; Guo, Jing; Lee, Joe; Mane, Karim; Milne, Kate; Green, Anthony R.; Chevassut, Timothy; Campbell, Peter J.; Ellinor, Patrick T.; Huntly, Brian J. P.; Baxter, E. Joanna; Nangalia, Jyoti Share Save
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome Garcia-Manero, Guillermo; Gaddh, Manila; Platzbecker, Uwe; Lindsley, R. Coleman; Larson, Sarah M.; Chevassut, Timothy; Fenaux, Pierre; Komrokji, Rami; Lyons, Roger; Al-Kali, Aref; Jiang, Yu; Bothos, John; Townsley, Danielle M.; Zeidan, Amer M. Share Save
Share Save
Share Save
Share Save
Share Save
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial) Kong, Robert; Hutchinson, Nevil; Hill, Andrew; Ingoldby, Fiona; Skipper, Nicola; Jones, Christopher; Bremner, Stephen; Bruce, Chloe; Wright, Juliet; Lewis, Michael; Newman, Stanton; Chevassut, Timothy; Hildick-Smith, David Share Save
Share Save
Share Save
Share Save
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial Ravandi, Farhad; Roboz, Gail J.; Wei, Andrew H.; Dohner, Hartmut; Pocock, Christopher; Selleslag, Dominik; Montesinos, Pau; Sayar, Hamid; Musso, Maurizio; Figuera-Alvarez, Angela; Safah, Hana; Tse, William; Sohn, Sang Kyun; Hiwase, Devendra; Chevassut, Timothy; Pierdomenico, Francesca; La Torre, Ignazia; Skikne, Barry; Bailey, Rochelle; Zhong, Jianhua; Beach, C. L.; Dombret, Herve Share Save
BRD4-mediated repression of p53 is a target for combination therapy in AML Latif, Anne-Louise; Newcombe, Ashley; Li, Sha; Gilroy, Kathryn; Robertson, Neil A.; Lei, Xue; Stewart, Helen J. S.; Cole, John; Terradas, Maria Terradas; Rishi, Loveena; McGarry, Lynn; McKeeve, Claire; Reid, Claire; Clark, William; Campos, Joana; Kirschner, Kristina; Davis, Andrew; Lopez, Jonathan; Sakamaki, Jun-ichi; Morton, Jennifer P.; Ryan, Kevin M.; Tait, Stephen W. G.; Abraham, Sheela A.; Holyoake, Tessa; Higgins, Brian; Huang, Xu; Blyth, Karen; Copland, Mhairi; Chevassut, Timothy J. T.; Keeshan, Karen; Adams, Peter D. Share Save
DIS3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers Robinson, Sophie R.; Viegas, Sandra C.; Matos, Rute G.; Domingues, Susana; Bedir, Marisa; Stewart, Helen J. S.; Chevassut, Timothy J.; Oliver, Antony W.; Arraiano, Cecilia M.; Newbury, Sarah F. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Autoimmunity as the Consequence of a Spontaneous Mutation in Rasgrp1 (vol 19, pg 243, 2003) Layer, Katrin; Lin, Guosheng; Nencion, Alessio; Hu, Wei; Schmucker, Adam; Antov, Andrey N.; Li, Xiaoyu; Takamatsu, Satoshi; Chevassut, Timothy; Dower, Nancy A.; Stang, Stacey L.; Beier, David; Buhlmann, Janet; Bronson, Roderick T.; Elkon, Keith B.; Stone, James C.; Van Parijs, Luk; Lim, Bing Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save